These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29148755)

  • 21. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.
    Abrahams KA; Cox JA; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Fernández R; Alemparte C; Remuiñán MJ; Barros D; Ballell L; Besra GS
    PLoS One; 2012; 7(12):e52951. PubMed ID: 23300833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration.
    van der Westhuyzen R; Winks S; Wilson CR; Boyle GA; Gessner RK; Soares de Melo C; Taylor D; de Kock C; Njoroge M; Brunschwig C; Lawrence N; Rao SP; Sirgel F; van Helden P; Seldon R; Moosa A; Warner DF; Arista L; Manjunatha UH; Smith PW; Street LJ; Chibale K
    J Med Chem; 2015 Dec; 58(23):9371-81. PubMed ID: 26551248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterium tuberculosis High-Throughput Screening.
    White EL; Tower NA; Rasmussen L
    Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yeast three-hybrid screening for identifying anti-tuberculosis drug targets.
    Moser S; Johnsson K
    Chembiochem; 2013 Nov; 14(17):2239-42. PubMed ID: 24133019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel dihydropyrimidines as a potential new class of antitubercular agents.
    Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
    Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.
    Tangallapally RP; Yendapally R; Lee RE; Hevener K; Jones VC; Lenaerts AJ; McNeil MR; Wang Y; Franzblau S; Lee RE
    J Med Chem; 2004 Oct; 47(21):5276-83. PubMed ID: 15456272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB.
    Cleghorn LAT; Ray PC; Odingo J; Kumar A; Wescott H; Korkegian A; Masquelin T; Lopez Moure A; Wilson C; Davis S; Huggett M; Turner P; Smith A; Epemolu O; Zuccotto F; Riley J; Scullion P; Shishikura Y; Ferguson L; Rullas J; Guijarro L; Read KD; Green SR; Hipskind P; Parish T; Wyatt PG
    J Med Chem; 2018 Aug; 61(15):6592-6608. PubMed ID: 29944372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
    Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
    ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
    Ng PS; Manjunatha UH; Rao SP; Camacho LR; Ma NL; Herve M; Noble CG; Goh A; Peukert S; Diagana TT; Smith PW; Kondreddi RR
    Eur J Med Chem; 2015 Dec; 106():144-56. PubMed ID: 26544629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
    Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
    Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
    Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
    Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of dipiperidines as new antitubercular agents.
    Bogatcheva E; Hanrahan C; Chen P; Gearhart J; Sacksteder K; Einck L; Nacy C; Protopopova M
    Bioorg Med Chem Lett; 2010 Jan; 20(1):201-5. PubMed ID: 19917527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole cell screen based identification of spiropiperidines with potent antitubercular properties.
    Tantry SJ; Degiacomi G; Sharma S; Jena LK; Narayan A; Guptha S; Shanbhag G; Menasinakai S; Mallya M; Awasthy D; Balakrishnan G; Kaur P; Bhattacharjee D; Narayan C; Reddy J; Naveen Kumar CN; Shandil R; Boldrin F; Ventura M; Manganelli R; Hartkoorn RC; Cole ST; Panda M; Markad SD; Ramachandran V; Ghorpade SR; Dinesh N
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3234-45. PubMed ID: 26087937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
    Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
    ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.